Many people have been becoming more aware of SARMs in recent years. SARM stands for selective androgen receptor modulators, and they are a class of nonsteroidal investigational compounds originally developed by scientists for age and disease-related muscle wasting.
The Food and Drug Administration (FDA) has not approved SARMs for human consumption, and SARMs for sale at this time are only for laboratory research purposes.
SARMs are currently banned in some athletic communities and by anti-doping agencies. Athletes should not participate in clinical research with SARMs. This guide will discuss everything you should know about two of the most common SARMs, RAD 140 vs LGD 4033 (Testolone vs Ligandrol) and spell out the similarities and differences between them.
The Major Differences Between RAD 140 vs. Ligandrol
RAD 140 and ligandrol are SARMs that are similar in many ways, but they also have some significant differences. Both are still experimental compounds per the FDA; one has been studied for use in mammals more than the other and is currently further along in clinical trials (CS). Here are some of the major differences between the two:
- LGD 4033 has been studied more than RAD 140 and is currently in phase II CS.
- There has only been one phase I study on the use of Testolone in mammals.
- Ligandrol is stronger on a per-milligram basis.
- Both have been banned in competitive sports leagues, but it is far more common for athletes to test positive for LGD 4033. Athletes should not participate in CS or studies related to SARMs as they are banned by the WADA.
- While RAD 140 and Ligandrol both produce significant anabolic activity, RAD 140 has some mild androgenic properties have been studied as well.
- The half life of RAD 140 is longer than the half life of Ligandrol LGD 4033
- RAD 140’s cognitive benefits and neuroprotective effects are under study, which is why it has been researched in Alzheimer’s disease cases in mice.
- There are price differences between the two; LGD 4033 is generally lower in price than RAD 140.
Some similarities of RAD 140 vs LGD that they share are related to side effects stated by research found in mice studies. The next section will explore this for both.
Side Effects Under Study in Mice and RAD 140 vs LGD 4033
Even though these are some of the best SARMs, there is limited information about the side effects of RAD 140 vs LGD 4033 due to the lack of clinical research available on them, but researchers have documented and are currently studying some of the effects of these SARMs in mammals. Here are some to be aware of:
RAD 140 and Ligandrol Suppress Natural Testosterone Levels
SARMS are not steroids but still exert their effects through the androgen receptor according to several research articles. If true, this would indicate these products elicit testosterone suppression.
The known side effects of androgen receptors leads to decreased testosterone and researchers list the following as being affected: erectile dysfunction, infertility, reduced libido, loss of bone density, muscle weakness, insomnia, depression, and weight gain accompanied by increased body fat.
Some Potentially Serious Side Effects
The FDA issued a public health advisory letter in October 2017 stating that “life-threatening reactions,” including liver toxicity, have occurred with a correlation to SARMs. They advised that SARMs have a strong impact on health and can increase the risk of cardiovascular events such as strokes or heart attacks.
Researchers have also noted effects on cholesterol, and are studying effects on HDL or “good” cholesterol. They have also found SARMs to cause GI issues and are researching the short and long-term effects.
Long-Term Effects Unknown
It’s important to remember that SARMs still don’t have FDA approval, and when looking at RAD 140 vs LGD 4033, they are still being studied in CS. On the flip side, this is why the long-term consequences are unknown and have not yet been studied. The lack of research also limits knowledge about potential drug interactions.
Please note: Both of these products are banned in numerous athletic leagues. They are not dietary or sports supplements and athletes should not participate in CS related to SARMs.
RAD 140’s Benefits Researchers Are Investigating
There are many known side effects of SARMs, but their original purpose of treating age and disease-related muscle loss continues to be explored by researchers. RAD 140 has also been studied for use against Alzheimer’s disease and breast cancer in mice. Here are some of the benefits researchers are testing with RAD 140:
- RAD 140 protected the prostate from androgens.
- LDL and triglycerides were lower after use of RAD 140 in some subjects.
- RAD 140 has shown neuroprotective and cognitive benefits.
- RAD 140 may increase lean body mass in some subjects.
RAD 140 has unfortunately not yet entered phase II clinical studies, so there is much for researchers to discover about this SARM’s potential. Research need to study other areas of this compound as well such as its effect on water retention or loss that can be associated with common heart health issues mentioned by the FDA.
Ligandrol’s Benefits Researchers are Investigating
LGD 4033 is the second most popular SARM on the market (after Ostarine). Below are some of the benefits that researchers have associated with the use of Ligandrol in mammalian studies:
- There was a high affinity for lean muscle mass and it was generally well-maintained after cessation in studies with primates, meaning muscle gain from LGD 4033 are likely sustainable for the long term.
- LGD 4033 is thus far shown to be the most potent SARM for increasing muscle tissue.
- It produced a faster recovery of healing of muscle, bone, and connective tissue post-injury and post-surgery.
SARMs such as RAD 140 and Ligandrol risks must be assessed. The FDA’s lack of approval of SARMs, and the fact that they’re banned in so many athletic leagues, means they should only be considered for laboratory research purposes only.
It is also important to note that SARMs packaged for human consumption are illegal, as is labeling them as dietary supplements. They can be purchased in their chemical form for research use only.
Those intending to conduct research should be sure to buy from a trusted supplier that does third party testing on their products and meets the standard of 98% purity set by researchers. Some products marketed as SARMs don’t actually contain SARMS, and some contain other unapproved compounds.
Visit the Sports Technology Labs Blog for news and information about SARMs
For the highest quality SARMs, look no further than Sports Technology Labs. Visit the Sports Technology Labs research blog for information about new products, updates in the industry, side effects, new scientific literature, and product comparisons.
Scientific References:
1. LoRusso, P., Hamilton, E., Ma, C., Vidula, N., Bagley, R. G., Troy, S., Annett, M., Yu, Z., Conlan, M. G., & Weise, A. (2022). A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer. Clinical breast cancer, 22(1), 67–77.
2. Anusha Jayaraman, Amy Christensen, V. Alexandra Moser, Rebekah S. Vest, Chris P. Miller, Gary Hattersley, Christian J. Pike, Selective Androgen Receptor Modulator RAD140 Is Neuroprotective in Cultured Neurons and Kainate-Lesioned Male Rats, Endocrinology, Volume 155, Issue 4, 1 April 2014, Pages 1398–1406,
3. National Center for Biotechnology Information (2022). PubChem Compound Summary for CID 44200882, Testolone. Retrieved December 2, 2022 from.
4. Yu Z, He S, Wang D, Patel HK, Miller CP, Brown JL, Hattersley G, Saeh JC. Selective androgen receptor modulator RAD140 inhibits the growth of androgen/estrogen receptor–positive breast cancer models with a distinct mechanism of action. American Association for Cancer Research. 2017 Dec 14 [accessed 2022 Apr 22].
5. Basaria et al. The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men. The Journals of Gerontology: Series A, Volume 68, Issue 1, January 2013, Pages 87–95.
6. Roch, P. J., Henkies, D., Carstens, J. C., Krischek, C., Lehmann, W., Komrakova, M., & Sehmisch, S. (2020). Ostarine and ligandrol improve muscle tissue in an ovariectomized rat model. Frontiers in endocrinology, 11, 556581.
7. Fragkaki et al. Human in vivo metabolism study of LGD-4033. Drug Test Analysis. Drug Test Anal. 2018 Nov;10(11-12):1635-1645. doi: 10.1002/dta.2512. Epub 2018 Nov 8.
8. Meyer L. FDA In Brief: FDA warns against using SARMs in body-building products. U.S. Food and Drug Administration. 2017 Oct. https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products
10. Wagener, F., Euler, L., Görgens, C., Guddat, S., & Thevis, M. (2022). Human in vivo metabolism and elimination behavior of micro-dosed selective androgen receptor modulator RAD140 for doping control purposes. Metabolites, 12(7), 666.
11. Miller, C. P., Shomali, M., Lyttle, C. R., O’Dea, L. S. L., Herendeen, H., Gallacher, K., … & Hattersley, G. (2011). Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140. ACS medicinal chemistry letters, 2(2), 124-129.
12. Fonseca, G. W. P. D., Dworatzek, E., Ebner, N., & Von Haehling, S. (2020). Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials. Expert Opinion on Investigational Drugs, 29(8), 881-891.